Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
DEL PRIS
SecurityDE:ABL / Abbott Laboratories
InstitutionFragasso Group Inc.
Latest Disclosed Ownership5,422 shares
Latest Disclosed Value $ 554,642
Fragasso Group Inc. reports 2.41% decrease in ownership of ABL / Abbott Laboratories

On April 7, 2026 - Fragasso Group Inc. filed a 13F-HR form disclosing ownership of 5,422 shares of Abbott Laboratories (DE:ABL) valued at $481,582 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 7, 2026 disclosing 5,556 shares of Abbott Laboratories. This represents a change in shares of -2.41% during the quarter. The current value of the position is $407,843 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 5,422 -134 -2.41 555 -20.40 0.0334
2026-01-07 2025-12-31 13F ABBOTT LABS COM 002824100 5,556 -972 -14.89 696 -20.73 0.0421
2025-10-06 2025-09-30 13F ABBOTT LABS COM 002824100 6,528 -484 -6.90 879 -7.87 0.0548
2025-07-09 2025-06-30 13F ABBOTT LABS COM 002824100 7,012 862 14.02 954 16.93 0.0643
2025-04-09 2025-03-31 13F ABBOTT LABS COM 002824100 6,150 188 3.15 816 20.92 0.0606
2025-01-13 2024-12-31 13F ABBOTT LABS COM 002824100 5,962 -32 -0.53 674 -1.32 0.0514
2024-10-07 2024-09-30 13F ABBOTT LABS COM 002824100 5,994 -29 -0.48 683 9.28 0.0525
2024-07-09 2024-06-30 13F ABBOTT LABS COM 002824100 6,023 235 4.06 626 -4.87 0.0516
2024-04-10 2024-03-31 13F ABBOTT LABS COM 002824100 5,788 163 2.90 658 6.14 0.0557
2024-01-08 2023-12-31 13F ABBOTT LABS COM 002824100 5,625 171 3.14 619 17.23 0.0564
2023-12-06 2023-09-30 13F ABBOTT LABS COM 002824100 5,454 -4 -0.07 528 -11.26 0.0555
2023-07-10 2023-06-30 13F ABBOTT LABS COM 002824100 5,458 -73 -1.32 595 6.25 0.0636
2023-04-13 2023-03-31 13F ABBOTT LABS COM 002824100 5,531 124 2.29 560 -5.56 0.0638
2023-01-24 2022-12-31 13F/A-1 ABBOTT LABS COM 002824100 5,407 -56 -1.03 594 12.10 0.0689
2022-10-13 2022-09-30 13F ABBOTT LABS COM 002824100 5,463 202 3.84 529 -7.52 0.0750
2022-08-30 2022-06-30 13F ABBOTT LABS COM 002824100 5,261 18 0.34 572 -7.89 0.0771
2022-04-06 2022-03-31 13F ABBOTT LABS COM 002824100 5,243 15 0.29 621 -15.62 0.0732
2022-01-19 2021-12-31 13F ABBOTT LABS COM 002824100 5,228 -686 -11.60 736 5.29 0.0869
2021-10-08 2021-09-30 13F ABBOTT LABS COM 002824100 5,914 593 11.14 699 13.29 0.0924
2021-07-19 2021-06-30 13F ABBOTT LABS COM 002824100 5,321 21 0.40 617 -2.83 0.0826
2021-05-27 2021-03-31 13F ABBOTT LABS COM 002824100 5,300 83 1.59 635 11.21 0.0892
2021-02-04 2020-12-31 13F ABBOTT LABS COM 002824100 5,217 12 0.23 571 0.88 0.0852
2020-11-05 2020-09-30 13F ABBOTT LABS COM 002824100 5,205 15 0.29 566 7.81 0.0943
2020-08-10 2020-06-30 13F ABBOTT LABS COM 002824100 5,190 17 0.33 525 28.68 0.0893
2020-05-14 2020-03-31 13F ABBOTT LABS COM 002824100 5,173 -52 -1.00 408 -10.13 0.0927
2020-02-13 2019-12-31 13F ABBOTT LABS COM 002824100 5,225 85 1.65 454 5.58 0.0764
2019-11-13 2019-09-30 13F ABBOTT LABS COM 002824100 5,140 16 0.31 430 -0.23 0.0797
2019-08-13 2019-06-30 13F ABBOTT LABS COM 002824100 5,124 18 0.35 431 5.64 0.0852
2019-05-08 2019-03-31 13F ABBOTT LABS COM 002824100 5,106 18 0.35 408 10.87 0.0871
2019-02-12 2018-12-31 13F ABBOTT LABS COM 002824100 5,088 16 0.32 368 3.08 0.0823
2018-11-13 2018-09-30 13F ABBOTT LABS COM 002824100 5,072 418 8.98 357 25.70 0.0864
2018-08-01 2018-06-30 13F ABBOTT LABS COM 002824100 4,654 0 0.00 284 1.79 0.0732
2018-05-14 2018-03-31 13F ABBOTT LABS COM 002824100 4,654 55 1.20 279 6.49 0.0691
2018-02-09 2017-12-31 13F ABBOTT LABS COM 002824100 4,599 0 0.00 262 6.94 0.0637
2017-11-13 2017-09-30 13F/A-1 ABBOTT LABS COM 002824100 4,599 4,599 245 0.0739
2015-01-21 2014-12-31 13F Abbott Laboratories COM 002824100 0 -6,120 -100.00 0 -100.00
2014-11-03 2014-09-30 13F Abbott Laboratories COM 002824100 6,120 115 1.92 255 2.83 0.1986
2014-08-15 2014-06-30 13F Abbott Laboratories COM 002824100 6,005 6,005 247 0.2178
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.